William Shakespeare - Theseus Pharmaceuticals CoFounder RD
| THRXDelisted Stock | USD 3.71 0.14 3.92% |
Insider
William Shakespeare is CoFounder RD of Theseus Pharmaceuticals
| Age | 61 |
| Phone | 857 400 9491 |
| Web | https://theseusrx.com |
William Shakespeare Latest Insider Activity
Tracking and analyzing the buying and selling activities of William Shakespeare against Theseus Pharmaceuticals stock is an integral part of due diligence when investing in Theseus Pharmaceuticals. William Shakespeare insider activity provides valuable insight into whether Theseus Pharmaceuticals is net buyers or sellers over its current business cycle. Note, Theseus Pharmaceuticals insiders must abide by specific rules, including filing SEC forms every time they buy or sell Theseus Pharmaceuticals'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
William Shakespeare over a year ago Exercise or conversion by William Shakespeare of 251084 shares of Theseus Pharmaceuticals subject to Rule 16b-3 |
Theseus Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (0.1789) % which means that it has lost $0.1789 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2555) %, meaning that it created substantial loss on money invested by shareholders. Theseus Pharmaceuticals' management efficiency ratios could be used to measure how well Theseus Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Theseus Pharmaceuticals currently holds 3.98 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Theseus Pharmaceuticals has a current ratio of 26.99, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Theseus Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Jason Barker | Arcus Biosciences | 49 | |
| Aseem Ansari | Design Therapeutics | N/A | |
| Keith MD | X4 Pharmaceuticals | 53 | |
| Robert II | Arcus Biosciences | 51 | |
| Brett Hall | Immuneering Corp | 55 | |
| Jaa Roberson | Day One Biopharmaceuticals | N/A | |
| Mary DiBiase | X4 Pharmaceuticals | 63 | |
| Leila MD | Pmv Pharmaceuticals | 61 | |
| Jenna Cohen | Blueprint Medicines Corp | N/A | |
| Mark Vignola | Terns Pharmaceuticals | 46 | |
| Mohamedi MBA | Immuneering Corp | N/A | |
| Filip MD | Monte Rosa Therapeutics | 50 | |
| Richard MD | X4 Pharmaceuticals | 61 | |
| Osvaldo Flores | Century Therapeutics | 61 | |
| Chandra Lovejoy | Erasca Inc | 53 | |
| Tracey Esq | Blueprint Medicines Corp | 56 | |
| MA MBA | Relay Therapeutics | 48 | |
| Linda Higgins | Arcus Biosciences | N/A | |
| Sharon Townson | Monte Rosa Therapeutics | 49 | |
| Christine MBA | Hookipa Pharma | 59 | |
| Ajim CFA | Monte Rosa Therapeutics | 47 | |
Management Performance
| Return On Equity | -0.26 | |||
| Return On Asset | -0.18 |
Theseus Pharmaceuticals Leadership Team
Elected by the shareholders, the Theseus Pharmaceuticals' board of directors comprises two types of representatives: Theseus Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Theseus. The board's role is to monitor Theseus Pharmaceuticals' management team and ensure that shareholders' interests are well served. Theseus Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Theseus Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| DPhil DPHIL, CoFounder Chairman | ||
| Timothy Clackson, Pres CEO | ||
| Len Rozamus, VP Operations | ||
| Nachu Narasimhan, VP Safety | ||
| Bradford Dahms, Chief officer | ||
| WeiSheng Huang, CoFounder Chemistry | ||
| Alicja Januszewicz, VP Culture | ||
| Victor Rivera, VP CoFounder | ||
| Benjamin Enerson, VP Affairs | ||
| Kristine CPA, VP Controller | ||
| MA DPHIL, CoFounder Chairman | ||
| David MD, Chief Officer | ||
| William Shakespeare, CoFounder RD |
Theseus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Theseus Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.26 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | (20.19 M) | |||
| Shares Outstanding | 44.65 M | |||
| Shares Owned By Insiders | 2.55 % | |||
| Shares Owned By Institutions | 93.28 % | |||
| Number Of Shares Shorted | 401.68 K | |||
| Price To Earning | 737.67 X | |||
| Price To Book | 0.81 X | |||
| EBITDA | (66.44 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |